Hydrochloric Acid

Hydrochloric Acid

SCHEMBL2120376

[Cl-].[Cl-].[Ni+2].c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.86

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE known ✓ P22303 1/20 0.32
TDP1 Q9NUW8 3/20 0.86
CYP3A4 P08684 1/20 0.86
ESR1 P03372 4/20 0.60
ESR2 Q92731 4/20 0.60
KDM4E B2RXH2 1/20 0.52
GAA P10253 1/20 0.52
NPSR1 Q6W5P4 1/20 0.35
ALDH1A1 P00352 3/20 0.35
DRD1 P21728 2/20 0.34
NOTUM Q6P988 1/20 0.32
TSHR P16473 3/20 0.32
CA1 P00915 2/20 0.32
CA2 P00918 2/20 0.32
CA9 Q16790 2/20 0.32
LMNA P02545 2/20 0.32
CA12 O43570 1/20 0.32
GLA P06280 1/20 0.32
CA3 P07451 1/20 0.32
CA4 P22748 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL11675266 1.00 TDP1 (0.86) TDP1CYP3A4ESR1ESR2KDM4E
Hydrochloric Acid SCHEMBL3209197 1.00 TDP1 (0.86) TDP1CYP3A4ESR1ESR2KDM4E
Hydrochloric Acid SCHEMBL62978 1.00 TDP1 (0.86) TDP1CYP3A4ESR1ESR2KDM4E
Hydrochloric Acid SCHEMBL6939763 0.97 TDP1 (0.80) TDP1CYP3A4ESR1ESR2KDM4E
Ammonia Solution, Strong SCHEMBL6935288 0.97 TDP1 (0.80) TDP1CYP3A4ESR1ESR2KDM4E
Hydrochloric Acid SCHEMBL11863762 0.93 TDP1 (0.86) TDP1CYP3A4ESR1ESR2KDM4E
Hydrochloric Acid SCHEMBL5915259 0.93 TDP1 (0.86) TDP1CYP3A4ESR1ESR2KDM4E
Iodide SCHEMBL11676491 0.93 TDP1 (0.86) TDP1CYP3A4ESR1ESR2KDM4E
Hydrochloric Acid SCHEMBL11072538 0.93 TDP1 (0.86) TDP1CYP3A4ESR1ESR2KDM4E
Hydrochloric Acid SCHEMBL8875 0.93 TDP1 (0.86) TDP1CYP3A4ESR1ESR2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4634145-A1 METHOD FOR SEPARATING A MIXED HYDROCARBON STREAM COMPRISING N-BUTENES USING A DIVIDING WALL DISTILLATION COLUMN MAKING N-BUTENES AND SEPARATION THEREOF BASF SE (DE) 2025-10-22 EP disclosed
WO-2024105087-A1 METHOD FOR SEPARATING A MIXED HYDROCARBON STREAM COMPRISING N-BUTENES USING A DIVIDING WALL DISTILLATION COLUMN MAKING N-BUTENES AND SEPARATION THEREOF BASF SE (DE) 2024-05-23 WO disclosed
EP-3536678-B1 PROCESS FOR PRODUCING PROPYLENE AND ALKYLATE LYONDELL CHEMICAL TECH LP (US) 2020-10-21 EP disclosed
US-10737992-B2 Methods of forming propylene and alkylate LYONDELL CHEMICAL TECHNOLOGY, L.P. (US) 2020-08-11 US disclosed
US-20190276378-A1 METHODS OF FORMING PROPYLENE AND ALKYLATE LYONDELL CHEMICAL TECHNOLOGY, L.P. (US) 2019-09-12 US disclosed
EP-3536678-A1 PROCESS FOR PRODUCING PROPYLENE AND ALKYLATE Lyondell Chemical Technology, L.P. (US) 2019-09-11 EP disclosed
US-8395005-B2 Production of 1-butene and propylene from ethylene EQUISTAR CHEMICALS, LP (US) 2013-03-12 US disclosed
US-20120095275-A1 Production of 1-Butene and Propylene From Ethylene LYONDELL CHEMICAL TECHNOLOGY, L.P. (US) 2012-04-19 US disclosed
WO-2012051427-A1 PRODUCTION OF 1-BUTENE AND PROPYLENE FROM ETHYLENE EQUISTAR CHEMICALS, LP (US) 2012-04-19 WO disclosed
US-20090269645-A1 POLYMER, POLYMER ELECTROLYTE AND FUEL CELL USING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-10-29 US disclosed
EP-1721922-A1 METHOD FOR PRODUCING POLYMER COMPOUND Sumitomo Chemical Company, Limited (JP) 2006-11-15 EP disclosed
EP-0655071-B1 METHOD OF PREPARING 1-METHYL-3-KETO-$g(D)?1,4 -STEROIDS SCHERING AG (DE) 1997-08-13 EP disclosed
US-5523428-A Process for the production of 1-methyl-3-keto-Δ1,4 steroids SCHERING AKTIENGESELLSCHAFT (DE) 1996-06-04 US disclosed
EP-0655071-A1 METHOD OF PREPARING 1-METHYL-3-KETO--g(D)?1,4 -STEROIDS. SCHERING AG (DE) 1995-05-31 EP disclosed
WO-1994004553-A1 METHOD OF PREPARING 1-METHYL-3-KETO-Δ1,4-STEROIDS SCHERING AKTIENGESELLSCHAFT (DE) 1994-03-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10737992-B2 Methods of forming propylene and alkylate APEX1, ALKBH3, PNN ACHE 1536/4885TDP1 247/4885CYP3A4 150/4885
US-20190276378-A1 METHODS OF FORMING PROPYLENE AND ALKYLATE APEX1, ALKBH3, PNN ACHE 1536/4885TDP1 247/4885CYP3A4 150/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.